Basic & Translational Research

Californian researchers discover 261 new genes for hereditary eye disease

The research tackling the pressing and substantial need for new gene medications targeting conventional aqueous outflow

Uncovering the complex biochemistry behind cataract formation

New advances in regenerative medicine bring hope to patients suffering from blinding disorders of the outer retina.

Researchers pin-point the moment our brains combine separate visual signals into a singular view

Approvals, announcements, acquisitions and an all-new training program for refractive surgeons

Introducing a personalized antisense gene therapy for inherited retinal diseases

Taken at differing anatomic depths, these monochromatic volume scans offer a detailed visualization of the superior arcade of a non-human primate.

Squalamine may have fascinating origins – originally derived from the livers of the dogfish shark – but as a treatment for wet AMD it has so far failed to have any “bite.”

Sitting Down With… John Berdahl, Partner at Vance Thompson Vision, Founder and CEO of Equinox, Sioux Falls, South Dakota, USA.